More stories

  • in

    Ina Jaffe, Dogged and Award-Winning NPR Reporter, Dies at 75

    Ms. Jaffe spent decades covering politics and aging in America, and she was the first editor of the NPR program “Weekend Edition Saturday.”Ina Jaffe, an NPR correspondent for roughly 40 years who was known for her unflinching approach to journalism and was the first editor of the network’s initial iteration of the weekly national news show “Weekend Edition Saturday,” died on Thursday. She was 75.Ms. Jaffe, who had been living with metastatic breast cancer for several years, died at a nursing home in Los Angeles, said her husband, Lenny Kleinfeld.Often described by her colleagues at NPR as a “reporter’s reporter,” Ms. Jaffe had a keen sense of the line separating the equitable and the unjust. The breadth of her journalistic expertise grew over the decades, beginning with the politics beat and evolving in later years to analyses that chronicled what it means to grow older in America.In addition to “Weekend Edition,” she contributed stories for the daily afternoon news program “All Things Considered.”In 2012, Ms. Jaffe reported on the Department of Veterans Affairs in Los Angeles leasing large areas of its campus that had been intended to house homeless veterans to unrelated businesses. In part because of a series of stories that she reported, the administration slated more land to be developed to provide housing for homeless veterans. In 2018, two men involved in the lease deals were sentenced on fraud charges.The series won an award from the Society of Professional Journalists and a Gracie Award from the Alliance for Women in Media.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Breast Cancer Survival Not Boosted by Double Mastectomy, Study Says

    A large study showed that for most patients, having both breasts removed after cancer was detected in one made no difference.For the more than 310,000 women diagnosed with breast cancer every year, no matter how well the treatment goes, there is always a lingering fear. Could the disease come back, even years later? And what if it comes back in the other breast? Could they protect themselves today by having a double mastectomy?A study has concluded that there is no survival advantage to having the other breast removed. Women who had a lumpectomy or a mastectomy and kept their other breast did just as well as women who had a double mastectomy, Dr. Steven Narod of Women’s College Hospital in Toronto and his colleagues reported, using U.S. data from more than 661,000 women with breast cancer on one side.In the study, published in JAMA Oncology on Thursday, the researchers added that most women did very well — the chance of cancer in the other breast was about 7 percent over 20 years.But the study’s results may not apply to women who have a gene variant, BRCA1 or BRCA2, which greatly increases their cancer risk. For the 1 in 500 American women with this variant, cancer researchers agree that it’s worth considering a double mastectomy.The finding that a double mastectomy is not protective against death for many breast cancers seems counterintuitive, Dr. Narod admitted. An accompanying editorial, by Dr. Seema Ahsan Khan, a breast cancer surgeon at Northwestern University, and Masha Kocherginsky, a biostatistician also at Northwestern, called it a conundrum.Previous smaller studies have come to the same conclusion. But, Dr. Narod said, some doctors have questioned the methods in earlier research. We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Shannen Doherty, ‘Beverly Hills, 90210’ Star, Dies at 53

    Shannen Doherty, the raven-haired actress known for playing headstrong characters in the 1990s television dramas “Beverly Hills, 90210” and “Charmed,” and who had tried in recent years to shed her rebellious reputation, died on Saturday. She was 53.The cause was cancer, her publicist, Leslie Sloane, said in an emailed statement. Ms. Doherty learned she had breast cancer in February 2015 and had been open about her struggle with it in the years since. In the summer of 2016, she shaved her head as a group of friends stood by, and in 2017, she announced that the cancer was in remission. It returned in 2020, and in June 2023, Ms. Doherty announced that the cancer had spread to her brain. In November, she said it had spread to her bones.But she continued to work, and started a podcast that month.“I’m not done with living. I’m not done with loving. I’m not done with creating. I’m not done with hopefully changing things for the better,” she told People magazine. “I’m not done.”Ms. Doherty in 1996. “I have felt misunderstood my whole life,” she told People in 2019.Gary Null/NBCShannen Maria Doherty was born on April 12, 1971, in Memphis to John Doherty Jr., a mortgage consultant, and Rosa (Wright) Doherty, a beautician. By age 10, Shannen had established herself as a child actress, appearing as Jenny Wilder in 18 episodes of “Little House on the Prairie” and acting alongside Wilford Brimley and Deidre Hall in the NBC drama “Our House.”Those were quickly overshadowed by her performance as the acid-tongued, red-scrunchy-wearing Heather Duke in the 1988 movie “Heathers,” a campy comedy-thriller that starred Winona Ryder, Christian Slater and Ms. Doherty as students who fight for lunchroom domination as the body count begins to rise.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Senator Menendez’s Wife Is Being Treated for Breast Cancer

    Nadine Menendez is charged along with her husband, Senator Robert Menendez, in a complex bribery scheme. She will undergo a mastectomy.Nadine Menendez, the wife of Senator Robert Menendez, is being treated for breast cancer and will undergo a mastectomy, her husband revealed on Thursday.Mr. Menendez announced his wife’s cancer diagnosis in a statement released while he was in Federal District Court in Manhattan, where he is on trial on charges that he accepted hundreds of thousands of dollars in bribes in exchange for political favors.“We are of course concerned about the seriousness and advanced stage of the disease,” Mr. Menendez, 70, said in the statement. “We hope and pray for the best results.”The timing of the announcement, issued by his Senate office, was conspicuous and punctuated a remarkable first week on trial. It came less than a day after the senator’s lawyers told jurors in an opening statement that Ms. Menendez, 57, was largely to blame for the gold bars and other lucrative bribes prosecutors say he took in exchange for helping Egypt and New Jersey businessmen.Mr. Menendez said he was releasing the information now because of “constant press inquiries and reporters following my wife.” He asked that she be given privacy as she battles cancer, which he described as “grade 3.”A lawyer for Ms. Menendez could not immediately be reached for comment. Ms. Menendez has not appeared in court.Ms. Menendez was originally scheduled to stand trial with him and two other defendants beginning this week. But last month, the judge presiding over the case, Sidney H. Stein, agree to grant her a delay and separate trial in July after her lawyers informed the court that she was dealing with a “serious medical condition” that would require surgery.The disclosure prompted widespread speculation in New Jersey political circles. But at the time, the lawyers only shared details of her diagnosis in a sealed submission to Judge Stein, withholding it from the public.The couple have both been accused of conspiring to trade Mr. Menendez’s clout as a senator and leader of the Senate Foreign Relations Committee for lucrative bribes, including the gold bars, cash and a $60,000 convertible for Ms. Menendez. In opening statements on Wednesday, prosecutors described Ms. Menendez as a crucial “go-between” for the senator and New Jersey businessmen accused of providing the payoffs.The senator and his wife have both pleaded not guilty. More

  • in

    Katie Couric’s Breast Cancer Diagnosis

    More from our inbox:L.G.B.T. Rights in Singapore: The Government’s ViewStanding by the Filmmaker in the ‘Jihad’ ControversyA Question for Election Deniers Karsten Moran for The New York TimesTo the Editor:Re “Katie Couric Talks About Her Breast Cancer Diagnosis” (nytimes.com, Sept. 28):Bravo to Katie Couric not only for sharing her breast cancer diagnosis, but also for raising awareness about breast density, which is an independent risk factor for developing breast cancer.Women with dense breasts have a higher incidence of breast cancer. Compounding this increased risk is the fact that mammograms of dense breasts — breasts with a higher proportion of fibroglandular tissue compared with fatty tissue — are less effective at identifying cancers because the dense tissue can obscure signs of breast cancer and lower the sensitivity of the image.In 2018 the Brem Foundation to Defeat Breast Cancer helped to pass a Washington, D.C., law requiring health care facilities to provide mammography results, including patients’ breast tissue classification, to patients. The law also requires insurance coverage for essential screenings beyond mammograms — such as ultrasound — that women with dense breasts and other risk factors need to diagnose their breast cancer. Similar bills have been passed in many states.It is high time that the Food and Drug Administration take action at the federal level to address breast density and modernize breast cancer screening and diagnosis. Doing so will save countless lives.Clare DoughertyWashingtonThe writer is C.E.O. of the Brem Foundation to Defeat Breast Cancer.L.G.B.T. Rights in Singapore: The Government’s ViewTo the Editor:Joel Tan, a gay Singaporean playwright, writes, “I Have Worked and Loved in Other Countries Because I Can’t at Home” (Opinion guest essay, Sept. 26).Many L.G.B.T. people lead fulfilling lives in Singapore. They do so in all fields, including Mr. Tan’s, the arts.This is not to minimize his pain, but L.G.B.T. rights remain divisive issues everywhere, including in the United States.In Singapore, too — by some measures the world’s most religiously diverse nation — people hold very divergent views on L.G.B.T. rights.In 2007, the government decided not to enforce Section 377A of the Penal Code, which criminalizes sex between men, but left the law itself unchanged.Fifteen years later, Singaporeans have become more accepting of homosexuals, enabling us to repeal Section 377A, and thus provide some relief to gay Singaporeans.But the majority of Singaporeans, not just a few “hard-line conservatives,” continue to believe that marriage must be between a man and a woman.The Singapore courts are not the right forum to decide this issue. So we are amending our Constitution to ensure that same-sex marriage cannot become legal through a court challenge. It can happen only if Parliament legislates to allow it.The current ruling party has said it will not do this, but neither will it tie the hands of future parliaments.Reaching a political accommodation balancing different legitimate views takes time. All sides must recognize that no party in this deeply divisive matter should expect to enforce its views on all.Our goal is to hold our society together, and avoid tearing ourselves apart in self-righteous fury.Ashok Kumar MirpuriWashingtonThe writer is Singapore’s ambassador to the United States.Standing by the Filmmaker in the ‘Jihad’ ControversyAfter criticism by Arab American and Muslim filmmakers led to the film being shunned by festivals, Meg Smaker renamed her documentary “The UnRedacted.”Tai Power Seeff for The New York TimesTo the Editor:Re “Film on Jihad Causes Storm Over Identity” (front page, Sept. 25):As co-executive producers of “Jihad Rehab,” we believe that the time and care that the filmmaker, Meg Smaker, took in researching the lives of the former Guantánamo detainees she portrayed, as well as the extent of her immersion in Muslim culture, did indeed qualify her to tell their story.The notion that a story can be truthfully depicted only by those of the same ethnicity and gender as its subjects would have, if applied through the ages, deprived the world of a great deal of important work. Yes, reports from inside a culture have a definite edge over interpretation by outsiders, but talent and perceptiveness and a desire to make the information available can counterbalance these advantages. It’s not an either/or question.Certainly Meg’s film wasn’t utterly flawless — few documentaries are — and she’s now made some minor adjustments to it, but it told a necessary, powerful human story that conveyed with great sympathy many facets of the experience of these particular men accused of terrorism.This is why we continued to support the film during the controversy surrounding it, and why we hope that audiences will soon be able to arrive at their own conclusions by viewing it for themselves. In the meantime, we proudly stand by Meg and her work.Jamie WolfNathalie SeaverLos AngelesMs. Wolf is the founder and president of Foothill Productions, and Ms. Seaver is its executive vice president.A Question for Election Deniers Illustration by Rebecca Chew/The New York Times; photograph by Stephen Maturen, via Getty ImagesTo the Editor:To help ensure integrity in governing, the following question needs to be asked, by reporters and constituents, of every candidate who believes that the 2020 presidential election was fraudulent:“So, you are running on the belief that the 2020 presidential election was fraudulent, even after many in-depth investigations were conducted, and dozens of lawsuits were filed, and they all showed that there was no evidence of fraud.“Therefore, please tell me what other beliefs and policy positions are in your campaign platform (and in your governing plans, if you are elected) that also have no evidence to support them?”Richard JohnsonMadison, Wis. More